Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Aescin for experimentally induced itch and wheal/flare in adults with type I allergy
2010-019373-15Phase 2Completed
- Sponsor
- Marinomed Biotech
- Start
- Apr 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of aescuven in atopic disease (4 arms), sponsored by Marinomed Biotech. Primary endpoint: Subjective reduction of itch at 20 minutes. Started Apr 2010; status: completed.
02
Drugs
aescuven
03
Conditions
atopic disease
Beyond the preview
Go deeper on 2010-019373-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019373-15.